These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28982876)

  • 1. Radical Cystectomy
    Haque W; Verma V; Butler EB; Teh BS
    Anticancer Res; 2017 Oct; 37(10):5603-5608. PubMed ID: 28982876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer Database.
    Fischer-Valuck BW; Rao YJ; Rudra S; Przybysz D; Germino E; Samson P; Baumann BC; Gay H; Michalski J
    J Urol; 2018 Feb; 199(2):416-423. PubMed ID: 28842247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base.
    Gray PJ; Fedewa SA; Shipley WU; Efstathiou JA; Lin CC; Zietman AL; Virgo KS
    Eur Urol; 2013 May; 63(5):823-9. PubMed ID: 23200811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer.
    Cahn DB; Handorf EA; Ghiraldi EM; Ristau BT; Geynisman DM; Churilla TM; Horwitz EM; Sobczak ML; Chen DYT; Viterbo R; Greenberg RE; Kutikov A; Uzzo RG; Smaldone MC
    Cancer; 2017 Nov; 123(22):4337-4345. PubMed ID: 28743162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder.
    Seisen T; Sun M; Lipsitz SR; Abdollah F; Leow JJ; Menon M; Preston MA; Harshman LC; Kibel AS; Nguyen PL; Bellmunt J; Choueiri TK; Trinh QD
    Eur Urol; 2017 Oct; 72(4):483-487. PubMed ID: 28412065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.
    Efstathiou JA; Spiegel DY; Shipley WU; Heney NM; Kaufman DS; Niemierko A; Coen JJ; Skowronski RY; Paly JJ; McGovern FJ; Zietman AL
    Eur Urol; 2012 Apr; 61(4):705-11. PubMed ID: 22101114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder.
    Fischer-Valuck BW; Rao YJ; Henke LE; Rudra S; Hui C; Baumann BC; Gay HA; Michalski JM
    Eur Urol Focus; 2018 Dec; 4(6):900-906. PubMed ID: 28919521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
    Giacalone NJ; Shipley WU; Clayman RH; Niemierko A; Drumm M; Heney NM; Michaelson MD; Lee RJ; Saylor PJ; Wszolek MF; Feldman AS; Dahl DM; Zietman AL; Efstathiou JA
    Eur Urol; 2017 Jun; 71(6):952-960. PubMed ID: 28081860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity matched comparative analysis of survival following chemoradiation or radical cystectomy for muscle-invasive bladder cancer.
    Ritch CR; Balise R; Prakash NS; Alonzo D; Almengo K; Alameddine M; Venkatramani V; Punnen S; Parekh DJ; Gonzalgo ML
    BJU Int; 2018 May; 121(5):745-751. PubMed ID: 29281848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
    Koga F; Fujii Y; Masuda H; Numao N; Yokoyama M; Ishioka J; Saito K; Kawakami S; Kihara K
    BJU Int; 2012 Sep; 110(6 Pt B):E203-8. PubMed ID: 22289431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term Mortality Associated with Definitive Chemoradiotherapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer.
    Haque W; Verma V; Aghazadeh M; Darcourt J; Butler EB; Teh BS
    Clin Genitourin Cancer; 2019 Oct; 17(5):e1069-e1079. PubMed ID: 31331865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Cancer Database Comparison of Radical Cystectomy vs Chemoradiotherapy for Muscle-Invasive Bladder Cancer: Implications of Using Clinical vs Pathologic Staging.
    Lin HY; Ye H; Kernen KM; Hafron JM; Krauss DJ
    Cancer Med; 2018 Nov; 7(11):5370-5381. PubMed ID: 30306728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation.
    Zhong J; Switchenko J; Jegadeesh NK; Cassidy RJ; Gillespie TW; Master V; Nieh P; Alemozaffar M; Kucuk O; Carthon B; Filson CP; Bilen MA; Jani AB
    Am J Clin Oncol; 2019 Jan; 42(1):36-41. PubMed ID: 29912804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
    Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
    JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of ERBB2 overexpression in therapeutic resistance and cancer-specific survival in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach.
    Inoue M; Koga F; Yoshida S; Tamura T; Fujii Y; Ito E; Kihara K
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):303-11. PubMed ID: 25304790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea.
    Kim SH; Seo HK; Shin HC; Chang SJ; Yun S; Joo J; Ku JH; Kim HS; Jeon HG; Jeong BC; Jeong IG; Kang SH; Hong B;
    J Korean Med Sci; 2015 Aug; 30(8):1150-6. PubMed ID: 26240494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol.
    Tanabe K; Yoshida S; Koga F; Inoue M; Kobayashi S; Ishioka J; Tamura T; Sugawara E; Saito K; Akashi T; Fujii Y; Kihara K
    Clin Genitourin Cancer; 2015 Aug; 13(4):e243-e251. PubMed ID: 25936588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative treatment and radical cystectomy for bladder cancer--a population based trend analysis of 10,338 patients in the Netherlands.
    Hermans TJN; Fransen van de Putte EE; Horenblas S; Lemmens V; Aben K; van der Heijden MS; Beerepoot LV; Verhoeven RH; van Rhijn BWG
    Eur J Cancer; 2016 Feb; 54():18-26. PubMed ID: 26707593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Treatment Strategies and Comparison of Outcomes in Lymph Node Positive Bladder Cancer: An Analysis of the National Cancer Database.
    Darwish C; Sparks A; Amdur R; Reddy A; Whalen M
    Urology; 2020 Dec; 146():168-176. PubMed ID: 32866509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing trends in urinary diversion after radical cystectomy for bladder cancer in the United States.
    Lin-Brande M; Nazemi A; Pearce SM; Thompson ER; Ashrafi AN; Djaladat H; Schuckman A; Daneshmand S
    Urol Oncol; 2019 Mar; 37(3):180.e1-180.e9. PubMed ID: 30482434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.